Monoacylglycerol Lipase Inhibitor therapy(Janssen Research & Development)

N/A

Report date: 2024/07/10 17:52:44
NME

Base Information

Drug NameMonoacylglycerol Lipase Inhibitor therapy(Janssen Research & Development)
Drug Alias Name[1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone,JNJ-42226314
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoglyceride lipase inhibitors
TargetsMonoglyceride lipase
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJanssen Research & Development Llc
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Research & Development Llc
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A